JDRF Strategic Research Agreement - Novel Adjunctive Therapeutic For T1D; a-MSH/MC5R agonist axis

Project: Research

Project Description

This proposal aims to test if α-MSH reduces blood glucose in people with type 1 diabetes, without affecting basal glucose levels, and to generate stable, specific analogues as lead drug development candidates.
Short titleα-MSH/MC5R axis as an adjunctive therapeutic target for type 1 diabetes
StatusActive
Effective start/end date1/07/1930/06/21